Thursday, April 30, 2020

Concerns over leaks compelled top U.S. infectious disease official Dr Anthony Fauci to reveal data on Gilead’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19